Does tocilizumab have an effect on the clinical outcomes in COVID-19 patients? A meta-analysis of randomized control trials

ConclusionThe administration of tocilizumab during the COVID-19 pandemic, prescribed to patients with the virus, exerted a noteworthy impact on reducing outcomes associated with COVID-19.
Source: Journal of Pharmaceutical Policy and Practice - Category: Pharmaceuticals Source Type: research